These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

355 related items for PubMed ID: 16880330

  • 1. Targeted disruption of the scavenger receptor and chemokine CXCL16 accelerates atherosclerosis.
    Aslanian AM, Charo IF.
    Circulation; 2006 Aug 08; 114(6):583-90. PubMed ID: 16880330
    [Abstract] [Full Text] [Related]

  • 2. CXCL16/SR-PSOX is an interferon-gamma-regulated chemokine and scavenger receptor expressed in atherosclerotic lesions.
    Wuttge DM, Zhou X, Sheikine Y, Wågsäter D, Stemme V, Hedin U, Stemme S, Hansson GK, Sirsjö A.
    Arterioscler Thromb Vasc Biol; 2004 Apr 08; 24(4):750-5. PubMed ID: 14988089
    [Abstract] [Full Text] [Related]

  • 3. Lentiviral vector-mediated siRNA knockdown of SR-PSOX inhibits foam cell formation in vitro.
    Zhang L, Liu HJ, Li TJ, Yang Y, Guo XL, Wu MC, Rui YC, Wei LX.
    Acta Pharmacol Sin; 2008 Jul 08; 29(7):847-52. PubMed ID: 18565283
    [Abstract] [Full Text] [Related]

  • 4. Atherogenic scavenger receptor modulation in the tubulointerstitium in response to chronic renal injury.
    Okamura DM, López-Guisa JM, Koelsch K, Collins S, Eddy AA.
    Am J Physiol Renal Physiol; 2007 Aug 08; 293(2):F575-85. PubMed ID: 17537985
    [Abstract] [Full Text] [Related]

  • 5. Cell surface-anchored SR-PSOX/CXC chemokine ligand 16 mediates firm adhesion of CXC chemokine receptor 6-expressing cells.
    Shimaoka T, Nakayama T, Fukumoto N, Kume N, Takahashi S, Yamaguchi J, Minami M, Hayashida K, Kita T, Ohsumi J, Yoshie O, Yonehara S.
    J Leukoc Biol; 2004 Feb 08; 75(2):267-74. PubMed ID: 14634054
    [Abstract] [Full Text] [Related]

  • 6. The chemokine and scavenger receptor CXCL16/SR-PSOX is expressed in human vascular smooth muscle cells and is induced by interferon gamma.
    Wågsäter D, Olofsson PS, Norgren L, Stenberg B, Sirsjö A.
    Biochem Biophys Res Commun; 2004 Dec 24; 325(4):1187-93. PubMed ID: 15555552
    [Abstract] [Full Text] [Related]

  • 7. Macrophage expression of peroxisome proliferator-activated receptor-alpha reduces atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Babaev VR, Ishiguro H, Ding L, Yancey PG, Dove DE, Kovacs WJ, Semenkovich CF, Fazio S, Linton MF.
    Circulation; 2007 Sep 18; 116(12):1404-12. PubMed ID: 17724261
    [Abstract] [Full Text] [Related]

  • 8. Chemokine SR-PSOX/CXCL16 expression in peripheral blood of patients with acute coronary syndrome.
    Yang HL, Xu YY, DU LF, Liu CH, Zhao Q, Wei WJ, You Y, Quan ZH.
    Chin Med J (Engl); 2008 Jan 20; 121(2):112-7. PubMed ID: 18272035
    [Abstract] [Full Text] [Related]

  • 9. CXCL16 is a marker of inflammation, atherosclerosis, and acute coronary syndromes in humans.
    Lehrke M, Millington SC, Lefterova M, Cumaranatunge RG, Szapary P, Wilensky R, Rader DJ, Lazar MA, Reilly MP.
    J Am Coll Cardiol; 2007 Jan 30; 49(4):442-9. PubMed ID: 17258089
    [Abstract] [Full Text] [Related]

  • 10. Enhanced expression and shedding of the transmembrane chemokine CXCL16 by reactive astrocytes and glioma cells.
    Ludwig A, Schulte A, Schnack C, Hundhausen C, Reiss K, Brodway N, Held-Feindt J, Mentlein R.
    J Neurochem; 2005 Jun 30; 93(5):1293-303. PubMed ID: 15934948
    [Abstract] [Full Text] [Related]

  • 11. SR-PSOX/CXCL16 plays a critical role in the progression of colonic inflammation.
    Uza N, Nakase H, Yamamoto S, Yoshino T, Takeda Y, Ueno S, Inoue S, Mikami S, Matsuura M, Shimaoka T, Kume N, Minami M, Yonehara S, Ikeuchi H, Chiba T.
    Gut; 2011 Nov 30; 60(11):1494-505. PubMed ID: 21471570
    [Abstract] [Full Text] [Related]

  • 12. Chemokine CXCL10 promotes atherogenesis by modulating the local balance of effector and regulatory T cells.
    Heller EA, Liu E, Tager AM, Yuan Q, Lin AY, Ahluwalia N, Jones K, Koehn SL, Lok VM, Aikawa E, Moore KJ, Luster AD, Gerszten RE.
    Circulation; 2006 May 16; 113(19):2301-12. PubMed ID: 16682613
    [Abstract] [Full Text] [Related]

  • 13. IL-18 accelerates atherosclerosis accompanied by elevation of IFN-gamma and CXCL16 expression independently of T cells.
    Tenger C, Sundborger A, Jawien J, Zhou X.
    Arterioscler Thromb Vasc Biol; 2005 Apr 16; 25(4):791-6. PubMed ID: 15604417
    [Abstract] [Full Text] [Related]

  • 14. Involvement of Escherichia coli in pathogenesis of xanthogranulomatous cholecystitis with scavenger receptor class A and CXCL16-CXCR6 interaction.
    Sawada S, Harada K, Isse K, Sato Y, Sasaki M, Kaizaki Y, Nakanuma Y.
    Pathol Int; 2007 Oct 16; 57(10):652-63. PubMed ID: 17803654
    [Abstract] [Full Text] [Related]

  • 15. Role of macrophage scavenger receptors in diet-induced atherosclerosis in mice.
    Sakaguchi H, Takeya M, Suzuki H, Hakamata H, Kodama T, Horiuchi S, Gordon S, van der Laan LJ, Kraal G, Ishibashi S, Kitamura N, Takahashi K.
    Lab Invest; 1998 Apr 16; 78(4):423-34. PubMed ID: 9564887
    [Abstract] [Full Text] [Related]

  • 16. CXCL16 is a novel mediator of the innate immunity of epidermal keratinocytes.
    Tohyama M, Sayama K, Komatsuzawa H, Hanakawa Y, Shirakata Y, Dai X, Yang L, Tokumaru S, Nagai H, Hirakawa S, Sugai M, Hashimoto K.
    Int Immunol; 2007 Sep 16; 19(9):1095-102. PubMed ID: 17855433
    [Abstract] [Full Text] [Related]

  • 17. Conditional knockout of macrophage PPARgamma increases atherosclerosis in C57BL/6 and low-density lipoprotein receptor-deficient mice.
    Babaev VR, Yancey PG, Ryzhov SV, Kon V, Breyer MD, Magnuson MA, Fazio S, Linton MF.
    Arterioscler Thromb Vasc Biol; 2005 Aug 16; 25(8):1647-53. PubMed ID: 15947238
    [Abstract] [Full Text] [Related]

  • 18. High levels and inflammatory effects of soluble CXC ligand 16 (CXCL16) in coronary artery disease: down-regulatory effects of statins.
    Smith C, Halvorsen B, Otterdal K, Waehre T, Yndestad A, Fevang B, Sandberg WJ, Breland UM, Frøland SS, Oie E, Gullestad L, Damås JK, Aukrust P.
    Cardiovasc Res; 2008 Jul 01; 79(1):195-203. PubMed ID: 18339644
    [Abstract] [Full Text] [Related]

  • 19. Attenuated expression of profilin-1 confers protection from atherosclerosis in the LDL receptor null mouse.
    Romeo GR, Moulton KS, Kazlauskas A.
    Circ Res; 2007 Aug 17; 101(4):357-67. PubMed ID: 17615372
    [Abstract] [Full Text] [Related]

  • 20. P55 tumour necrosis factor receptor in bone marrow-derived cells promotes atherosclerosis development in low-density lipoprotein receptor knock-out mice.
    Xanthoulea S, Gijbels MJ, van der Made I, Mujcic H, Thelen M, Vergouwe MN, Ambagts MH, Hofker MH, de Winther MP.
    Cardiovasc Res; 2008 Nov 01; 80(2):309-18. PubMed ID: 18628255
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.